Discontinuation of cholinesterase inhibitor treatment in institutionalised patients with advanced dementia

In study, cholinesterase inhibitor treatment was discontinued in 23 of 43 patients with advanced stage dementia and after 3 months, there was no clinical deterioration in terms of cognitive function, BPSD, or functional status in this group vs. those who continued treatment.


European Journal of Hospital Pharmacy